RxDoctor Payments Data

Kevin Au, MD

Vascular Surgery · Madison, WINPI 1417344219

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,755 of the $7,949 with a category attached, or 72.4%. 16 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 46.7% of the total. Reporting peaked in 2022 at $2,876 and has fallen 63.2% since, to $1,058 in 2025.

$7,949in general payments, 2019–2025

Across 71 payments — averaging $111.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • W. L. Gore & Associates, Inc.$4K
  • Terumo Medical Corporation$823
  • Inari Medical, Inc.$654
  • Silk Road Medical, Inc.$611
  • Cardiovascular Systems Inc.$428
  • Abbott$372
  • plus $1K from 10 others

What the payments were for

  • Travel & lodging$2,19428%
  • Food & beverage$5,75572%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,949 in reported general payments places this provider in the 80th percentile of 81 vascular surgery providers in Wisconsin.

See all vascular surgery providers in Wisconsin

Medicare billing

Part B allowed, 2024
$113,294
Medicare patients
304
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$7,936
ClopidogrelClopidogrel Bisulfate70$1,171
Atorvastatin Calcium65$540
Rosuvastatin Calcium24$416

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Madison

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →